Trends in the HIV related hospital admissions in the HAART era in Barbados, 2004-2006

AIDS Research and Therapy

Volumn 4, Issue , 2007, Pages

  Kumar, Alok ^a,b   Kilaru, Krishna R ^c   Sandiford, Shelly ^d   Forde, Sheila ^e  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b Ministry of Health ^*  (Barbados)

^c STI Program   (Barbados)

^d QUEEN ELIZABETH HOSPITAL   (Barbados)

^e Ministry of Health   (Barbados)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; BACTERIAL INFECTION; CD4 LYMPHOCYTE COUNT; CENTRAL AMERICA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SEASONAL VARIATION; TREND STUDY; VIRUS DIAGNOSIS;

EID: 69149087263     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-4-4     Document Type: Article

References (19)

1. Mocroft A, Monforte A, Kirk O, Johnson MA, Friis-Moller N, Banhegyi D, Blaxhult A, Mulcahy F, Gatell JM, Lundgren JD, EuroSIDA study group: Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study. HIV Med 2004, 5(6):437-47.
2. Sherer R, Pulvirenti J, Stieglitz K, Narra J, Jasek J, Green L, Moore B, Shott S, Cohen M: Hospitalization in HIV in Chicago. J Int Assoc Physicians AIDS Care (Chic Ill). Winter 2002, 1(1 26-33.
3. Paul S, Gilbert HM, Lande L, Vaamonde CM, Jacobs J, Malak S, Sepkowitz KA: Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Res Hum Retroviruses 18(7):501-6. 2002 May 1
4. Gebo KA, Diener-West M, Moore RD: Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy J Acquir Immune Defic Syndr 27(2):143-52. 2001 Jun 1
5. Floris-Moore M, Lo Y, Klein RS, Budner N, Gourevitch MN, Moskaleva G, Schoenbaum EE: Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 34(3 331-7. 2003 Nov 1
6. Fleishman JA, Gebo KA, Reilly ED, Conviser R, Christopher Mathews W, Todd Korthuis P, Hellinger J, Rutstein R, Keiser P, Rubin H, Moore RD, HIV Research Network: Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care 2005, 43(9 Suppl):III40-52.
7. Krentz HB, Dean S, Gill MJ: Longitudinal assessment (1995- 2003) of hospitalizations of HIV-infected patients within a geographical population in Canada. HIV Med 2006, 7(7):457-66.
8. Keiser P, Kvanli MB, Turner D, Reisch J, Smith JW, Nassar N, Gregg C, Skiest D: Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital. J Acquir Immune Defic Syndr Hum Retrovirol 20(1):28-33. 1999 Jan 1
9. Sok P, Harwell JI, McGarvey ST, Lurie M, Lynen L, Flanigan T, Mayer KH: Demographic and clinical characteristics of HIV-infected inpatients and outpatients at a Cambodian hospital. AIDS Patient Care STDS 2006, 20(5):369-78.
10. Sharma SK, Kadhiravan T, Banga A, Goyal T, Bhatia I, Saha PK: Spectrum of clinical disease in a series of 135 hospitalised HIVinfected patients from north India. BMC Infect Dis 4:52. 2004 Nov 22
11. Ogun SA, Adelowo OO, Familoni OB, Adefuye OB, Alebiosu C, Jaiyesimi AE, Fakoya EA, Odusan B, Odusoga OL, Ola OO: Spectrum and outcome of clinical diseases in adults living with AIDS at the Ogun State University Teaching Hospital. East Afr Med J 2003, 80(10 513-7.
12. St John AM, Kumar A, Cave C: Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados. Pediatr Infect Dis J 2003, 22(5 422-6.
13. Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC: Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country. HIV Med 2006, 7(2):99-104.
14. No authors listed: Country profile - Barbados. Pan American Health Organization (Regional Office of the World Health Organization). 2006 [http://www.paho.org/English/AIS/cp_052.htm]. Accessed 17 January 2006.
15. Caribbean Epidemiology Centre/Pan American Health Organization/ WHO. Status and trends: Analysis of the Caribbean HIV/AIDS epidemic 1982 - 2002. Caribbean Epidemiology Centre Publication 2004.
16. Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC: CD4 cell counts in adults with newly diagnosed HIV infection in Barbados. Pan-American Journal of Public Health 2004, 16(9):718-725.
17. Rutledge SE, Abell N: Awareness, acceptance, and action: An emerging framework for understanding AIDS stigmatizing attitudes among community leaders in Barbados. AIDS Patient Care & STDs 2005, 19(3) 186-199.
18. Perbost I, Malafronte B, Pradier C, Santo LD, Dunais B, Counillon E, Vinti H, Enel P, Fuzibet JG, Cassuto JP, Dellamonica P: In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection? HIV Med 2005, 6(4):232-9.
19. Manavi K, McMillan A: A significant proportion of HIBV-infected patients admitted to hospital have immunosuppression as a result of the failure of highly active antiretroviral therapy. HIV Med 2004, 5:360-363.